Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FLT3 |
| Variant | K429E |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | FLT3 K429E lies within the extracellular domain of the Flt3 protein (UniProt.org). K429E is predicted to confer a gain of function to the Flt3 protein, as demonstrated by transformation of cells in culture (PMID: 30651561). |
| Associated Drug Resistance | Y |
| Category Variants Paths |
FLT3 mutant FLT3 act mut FLT3 K429E |
| Transcript | NM_004119.3 |
| gDNA | chr13:g.28037209T>C |
| cDNA | c.1285A>G |
| Protein | p.K429E |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004119 | chr13:g.28037209T>C | c.1285A>G | p.K429E | RefSeq | GRCh38/hg38 |
| NM_004119.3 | chr13:g.28037209T>C | c.1285A>G | p.K429E | RefSeq | GRCh38/hg38 |
| NM_004119.2 | chr13:g.28037209T>C | c.1285A>G | p.K429E | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| FLT3 K429E | hematologic cancer | resistant | Crenolanib | Preclinical - Cell culture | Actionable | In a preclinical study, Crenolanib (CP-868596) did not decrease proliferation of transformed cells expressing FLT3 K429E in culture (PMID: 30651561). | 30651561 |